The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Apocynin inhibits peroxynitrite formation by murine macrophages
Open accessAbstract
Peroxynitrite (ONOO−) the highly reactive coupling product of nitric oxide and superoxide, has been implicated in the pathogenesis of an increasing number of (inflammatory) diseases. At present, however, selective peroxynitrite antagonizing agents with therapeutic potential are not available. Therefore, the NADPH‐oxidase inhibitor apocynin (4‐hydroxy‐3‐methoxy‐acetophenone) was tested for its ability to inhibit peroxynitrite formation in vitro The murine macrophage cell‐line J774A.1, stimulated with IFNγ/LPS, was used as a model. Conversion of 123‐dihydrorhodamine (123‐DHR) to its oxidation product 123‐rhodamine was used to measure peroxynitrite production. Stimulated peroxynitrite formation could be completely inhibited by apocynin, by the superoxide scavenger TEMPO as well as by the nitric oxide synthase inhibitor aminoguanidine. Apocynin and aminoguanidine specifically inhibited superoxide and nitric oxide formation respectively as confirmed by measuring lucigenin enhanced chemiluminescence and nitrite accumulation. It is concluded that J774A.1 macrophages produce significant amounts of peroxynitrite, which is associated with nitric oxide production and NADPH‐oxidase dependent superoxide formation. The NADPH‐oxidase inhibitor apocynin proved to be a potent inhibitor of both superoxide and peroxynitrite formation by macrophages, which may be of future therapeutic significance in a wide range of inflammatory disorders. British Journal of Pharmacology (2000) 130, 932–936; doi:10.1038/sj.bjp.0703401
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Beckman, J. S., Beckman, T. W., Chen, J., Marshall, P. A., & Freeman, B. A. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.4.1620 · Cited by 7,029 · cited 2×
“Peroxynitrite, a relatively stable intermediate, is formed by the diffusionlimited reaction of the free radicals nitric oxide (NO) and superoxide anion (⋅O2-) (1-3).”
BackgroundFormation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496 · cited 2×
“The formation of the putative peroxynitrite footprint 3-nitrotyrosine, for example, has been demonstrated to be readily catalyzed by myeloperoxidase with hydrogen peroxide and nitrite as substrates (Eiserich et al., 1998).”
BackgroundDirect EPR Detection of the Carbonate Radical Anion Produced from Peroxynitrite and Carbon Dioxide
Bonini, M. G., Radi, R., Ferrer-Sueta, G., Ferreira, A. M. D. C., & Augusto, O. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10802 · Cited by 293
The formation of peroxynitrite in vivo from nitric oxide and superoxide
Squadrito, G. L., & Pryor, W. A. (1995) · Chemico-Biological Interactions · doi:10.1016/0009-2797(94)03591-u · Cited by 200
Cited by
Yu, F., Li, P., Wang, B., & Han, K. (2013) · Journal of the American Chemical Society · doi:10.1021/ja401360a · Cited by 621
Yu, F., Li, P., Li, G., Zhao, G., Chu, T., & Han, K. (2011) · Journal of the American Chemical Society · doi:10.1021/ja202582x · Cited by 578
Yuan, L., Wang, L., Agrawalla, B. K., Park, S.-J., Zhu, H., Sivaraman, B., Peng, J., Xu, Q.-H., & Chang, Y.-T. (2015) · Journal of the American Chemical Society · doi:10.1021/jacs.5b00042 · Cited by 558
Cheng, D., Pan, Y., Wang, L., Zeng, Z., Yuan, L., Zhang, X., & Chang, Y.-T. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10508 · Cited by 500
Luminescent probes for the bioimaging of small anionic species in vitro and in vivo
Ashton, T. D., Jolliffe, K. A., & Pfeffer, F. M. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00372a · Cited by 367
Stefanska, J., & Pawliczak, R. (2008) · Mediators of Inflammation · doi:10.1155/2008/106507 · Cited by 348
A Highly Specific BODIPY-Based Fluorescent Probe for the Detection of Hypochlorous Acid
Sun, Z.-N., Liu, F.-Q., Chen, Y., Tam, P. K. H., & Yang, D. (2008) · Organic Letters · doi:10.1021/ol800507m · Cited by 341
Chen, T., Hu, Y., Cen, Y., Chu, X., & Lu, Y. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4035939 · Cited by 308
Cheng, D., Peng, J., Lv, Y., Su, D., Liu, D., Chen, M., Yuan, L., & Zhang, X. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b01374 · Cited by 308
Reactive Oxygen Species as Mediators in Asthma
Henricks, P. A. J., & Nijkamp, F. P. (2001) · Pulmonary Pharmacology & Therapeutics · doi:10.1006/pupt.2001.0319 · Cited by 293
Self-citationSakellariou, G. K., Vasilaki, A., Palomero, J., Kayani, A., Zibrik, L., McArdle, A., & Jackson, M. J. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4623 · Cited by 276
“The proposed inhibitory mechanism of action of APO on NADPH oxidases is to prevent the translocation of p47 and p67 to the membranelocated catalytic subunits (46) whereas gp91ds-tat peptide, the most potent inhibitor (IC50: 3 lM), has been reported to selectively inhibit NOX2 oxidase (14), although early studies sugge…”
Subramanian Vignesh, K., Landero Figueroa, J. A., Porollo, A., Caruso, J. A., & Deepe, G. S. (2013) · Immunity · doi:10.1016/j.immuni.2013.09.006 · Cited by 230
Inhibition of human vascular nadph oxidase by apocynin derived oligophenols
Mora-Pale, M., Weïwer, M., Yu, J., Linhardt, R. J., & Dordick, J. S. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.05.061 · Cited by 36
Wan, J., Bae, M.-A., & Song, B.-J. (2004) · Experimental & Molecular Medicine · doi:10.1038/emm.2004.10 · Cited by 32
Metadata
- Authors
- Muijsers, R. B. R., Van Den Worm, E., Folkerts, G., Beukelman, C. J., Koster, A. S., Postma, D. S., & Nijkamp, F. P.
- Venue
- British Journal of Pharmacology
- Publisher
- Wiley
- Published
- 2000-06
- Volume
- 130
- Issue
- 4
- Pages
- 932-936
- ISSN
- 0007-1188 (ISSN-L)
- 1476-5381
- OpenAlex
- W2003554652
- Cited by
- 160
- References
- 4
- FWCI
- 1.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.